Massachusetts Financial Services’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,242,859
Closed -$536M 962
2021
Q2
$536M Sell
3,242,859
-2,412,154
-43% -$403M 0.16% 150
2021
Q1
$867M Sell
5,655,013
-461,094
-8% -$62.6M 0.27% 108
2020
Q4
$767M Buy
6,116,107
+925,206
+18% +$103M 0.25% 112
2020
Q3
$527M Buy
5,190,901
+637,082
+14% +$65M 0.19% 126
2020
Q2
$443M Buy
4,553,819
+1,864,740
+69% +$174M 0.17% 133
2020
Q1
$223M Buy
2,689,079
+983,401
+58% +$95.9M 0.11% 174
2019
Q4
$190M Buy
1,705,678
+1,083,837
+174% +$111M 0.07% 223
2019
Q3
$61.7M Buy
+621,841
New +$61.8M 0.02% 385

Other funds holding PRAH

Massachusetts Financial Services's PRAH Position: Q3 2021 in Review

Massachusetts Financial Services sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,242,859 shares — an estimated $536M sold.

Massachusetts Financial Services first reported a position in PRAH in Q3 2019 and held it in 8 quarters. The position peaked at $867M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Massachusetts Financial Services reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 3,242,859 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $536M.
  • Massachusetts Financial Services first reported a position in PRA Health Sciences, Inc. in Q3 2019 and held it in 8 quarters.
  • Massachusetts Financial Services's PRA Health Sciences, Inc. position peaked at $867M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Massachusetts Financial Services's 13F filing for Q3 2021, filed 10 Nov 2021.